BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11848020)

  • 1. [Stromal leydig cell tumor coexisting with ascites].
    Czupkałło G; Jakowicki JA; Baranowski W
    Ginekol Pol; 2001 Oct; 72(10):825-8. PubMed ID: 11848020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Virilizing ovarian tumor: a rare cause of androgenetic alopecia].
    Bahloul E; Amouri M; Masmoudi A; Chaabene K; Mnif F; Makni S; Amouri H; Abid M; Boudawara T; Turki H
    Ann Dermatol Venereol; 2015 Apr; 142(4):303-4. PubMed ID: 25813185
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary amenorrhoea due to Leydig cell tumour.
    Elbadrawy M; Davies N
    J Obstet Gynaecol; 2005 Jul; 25(5):529-30. PubMed ID: 16183608
    [No Abstract]   [Full Text] [Related]  

  • 4. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
    Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
    Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
    Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
    Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
    Ferrinho C; Silva E; Oliveira M; Sequeira Duarte J
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33731391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of Leydig cell virilizing tumor of the ovary].
    Simonetti C; Di Vagno G; Cazzolla A; Melilli G; Di Gesú G; Cormio G; Selvaggi L
    Minerva Ginecol; 1998 Dec; 50(12):545-7. PubMed ID: 10069169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case.
    Loh KC; Lo JC; Zaloudek CJ; Fitzgerald PA
    Ann Acad Med Singap; 1998 Sep; 27(5):712-6. PubMed ID: 9919347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-Onset Type 2 Diabetes and Virilization in a Benign Sex Cord Tumor.
    Feiz F; Tehranian A; Heidary SS; Seifollahi A
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):S89-S91. PubMed ID: 28666491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia and hirsutism in a postmenopausal woman as the presenting complaint of ovarian hilus (Leydig) cell tumor.
    Berbegal L; Albares MP; De-Leon FJ; Negueruela G
    Actas Dermosifiliogr; 2015 Oct; 106(8):676-8. PubMed ID: 25910403
    [No Abstract]   [Full Text] [Related]  

  • 12. [Virilizing ovarian tumors in the menopausal patient].
    Nadeau C; Gibelin H; Breheret J; Fieuzal S; Lefort G; Kraimps JL
    J Chir (Paris); 2008; 145(5):493-5. PubMed ID: 19106875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of adrenal and ovarian venous sampling in the investigation of androgen-secreting tumours.
    Petersons CJ; Burt MG
    Intern Med J; 2011 Jan; 41(1a):69-70. PubMed ID: 21265966
    [No Abstract]   [Full Text] [Related]  

  • 14. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour.
    Persechini ML; Motton S; Leguevaque P; Donadille F; Escourrou G; Vierasu B; Hamdi S; Bennet A; Caron P
    Gynecol Endocrinol; 2011 May; 27(5):345-50. PubMed ID: 20569103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
    Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
    Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor.
    Faria AM; Perez RV; Marcondes JA; Freire DS; Blasbalg R; Soares J; Simões K; Hayashida SA; Pereira MA
    Nat Rev Endocrinol; 2011 Apr; 7(4):240-5. PubMed ID: 21321567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian thecoma with androgenic manifestations in a postmenopausal woman.
    Siekierska-Hellmann M; Sworczak K; Babińska A; Wojtylak S
    Gynecol Endocrinol; 2006 Jul; 22(7):405-8. PubMed ID: 16864153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
    Haning RV; Loughlin J; Shapiro SS
    Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leydig cell tumor in the post-menopausal woman: case report and literature review.
    Sherf S; Martinez D
    Acta Biomed; 2016 Jan; 87(3):310-313. PubMed ID: 28112699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
    Souto SB; Baptista PV; Braga DC; Carvalho D
    Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.